Bristol-Myers Squibb Co. et al.; Withdrawal of Approval of 70 New Drug Applications and 97 Abbreviated New Drug Applications
Health and Human Services Department; Food and Drug Administration · 2011
Read Bristol-Myers Squibb Co. et al.; Withdrawal of Approval of 70 New Drug Applications and 97 Abbreviated New Drug Applications by Health and Human Services Department; Food and Drug Administration (2011) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/uslaw-fr-2011-14164.txt.
Description
Notice published in the Federal Register on 2011-06-08 by Health and Human Services Department; Food and Drug Administration. Text from federalregister.gov (official edition: govinfo). [Pages 33310-33314] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2011-14164] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2011-N-0411] Bristol-Myers Squibb Co. et al.; Withdrawal of Approval of 70 New Drug Applications and 97 Abbreviated New.
Catalog record
| CREATOR | Health and Human Services Department; Food and Drug Administration |
|---|---|
| YEAR | 2011 |
| COLLECTION | LAW |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | Public Domain |
| RIGHTS | PUBLIC DOMAIN |
| SOURCE | Federal Register |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Bristol-Myers Squibb Co. et al.; Withdrawal of Approval of 70 New Drug Applications and 97 Abbreviated New Drug Applications Citation: us:fr:2011-14164 Creator: Health and Human Services Department; Food and Drug Administration Year: 2011 Source-URL: https://www.federalregister.gov/documents/2011/06/08/2011-14164/bristol-myers-squibb-co-et-al-withdrawal-of-approval-of-70-new-drug-applications-and-97-abbreviated Context: Notice published in the Federal Register on 2011-06-08 by Health and Human Services Department; Food and Drug Administration. Text from federalregister.gov (official edition: govinfo). [Pages 33310-33314] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2011-14164] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2011-N-0411] Bristol-Myers Squibb Co. et al.; Withdrawal of Approval of 70 New Drug Applications and 97 Abbreviated New Drug Applications AGENCY: Food and Drug Administration, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Food and Drug Administration (FDA) is withdrawing approval of 70 new drug applications (NDAs) and 97 abbreviated new drug applications (ANDAs) from multiple applicants. The holders of the applications notified the Agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn. DATES: Effective Date: July 8, 2011. FOR FURTHER INFORMATION CONTACT: Florine P. Purdie, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 51, rm. 6366, Silver Spring, MD 20993-0002, 301- 796-3601. SUPPLEMENTARY INFORMATION: The holders of the applications listed in table 1 of this document have informed FDA that these drug products are no longer marketed and have requested that FDA withdraw approval of the applications under the process in Sec. 314.150(c) (21 CFR 314.150(c)). The applicants have also, by their requests, waived their opportunity for a hearing. Withdrawal of approval of an application or abbreviated application under Sec. 314.150(c) is without prejudice to refiling. Table 1 ------------------------------------------------------------------------ Application No. Drug Applicant ------------------------------------------------------------------------ NDA 007289.................. Trigesic and Bristol-Myers Squibb Trigesic with Co., P.O. Box 4000, Codeine Tablets. Princeton, NJ 08543- 4000. NDA 008248.................. Wyamine Baxter Healthcare (mephentermine Corp., 2 Esterbrook sulfate) Sulfate Lane, Cherry Hill, Injection. NJ 08003-4099. NDA 008834.................. Tronothane HCl Abbott Laboratories, (pramoxine Dept. PA76/Bldg. hydrochloride AP30-1E, 200 Abbott (HCl)). Park Rd., Abbott Park, IL 60064- 6157. NDA 009182.................. Gantrisin Hoffman-La Roche, (sulfisoxazole Inc., 340 Kingsland acetyl). St., Nutley, NJ 07110-1199. NDA 011835.................. Hydrodiuril Merck & Co., Inc., (hydrochlorothiazid P.O. Box 1000, UG2C- e (HCTZ)) Tablets. 50, North Wales, PA 19454. NDA 011971.................. Oretic (HCTZ) Abbott Laboratories. Tablets, 25 milligrams (mg) and 50 mg. NDA 012302.................. Choloxin Do. (dextrothyroxine sodium) Tablets, 1 mg, 2 mg, 4 mg, and 6 mg. NDA 013402.................. Aldoril (methyldopa/ Merck & Co., Inc. HCTZ) Tablets. NDA 015539.................. Serax (oxazepam) Alpharma U.S. Capsules and Pharmaceuticals Tablets. Division, c/o King Pharmaceuticals, Inc., 501 Fifth St., Bristol, TN 37620. NDA 016118.................. Teslac Bristol-Myers Squibb (testolactone) Co. Tablets. NDA 016402.................. Alupent Boehringer (metaproterenol Ingelheim, 900 sulfate) Inhalation Ridgebury Rd., P.O. Aerosol \1\. Box 368, Ridgefield, CT 06877-0368. NDA 016666.................. Hippuran (hippuran I- Mallinckrodt Medical 131) Injection. Inc., c/o Covidien, 675 McDonnell Blvd., Hazelwood, MO 63042. NDA 016979.................. Megace (megestrol Bristol-Myers Squibb acetate) Tablets, Co. 20 mg and 40 mg. NDA 017015.................. Pavulon (pancuronium Organon USA Inc., c/ bromide) Injection. o Schering-Plough Corp., 2000 Galloping Hill Rd., Kenilworth, NJ 07033-0530. NDA 017352.................. Fastin (phentermine GlaxoSmithKline, HCl) Capsules. P.O. Box 13398, Five Moore Dr., Research Triangle Park, NC 27709- 3398. [[Page 33311]] NDA 017628.................. Tolectin (tolmetin Ortho-McNeil sodium) Tablets, Pharmaceutical, 200 mg and 600 mg. Inc., c/o Johnson & Johnson Pharmaceutical Research & Development, LLC, 1125 Trenton- Harbourton Rd., Titusville, NJ 08560-0200. NDA 017920.................. Tagamet (cimetidine) GlaxoSmithKline. Tablets, 100 mg, 200 mg, 300 mg, 400 mg, and 800 mg. NDA 017924.................. Tagamet (cimetidine) Do. Oral Solution, 300 mg/5 milliliters (mL). NDA 017933.................. Lente Iletin Eli Lilly and Co., (insulin zinc Lilly Corporate suspension purified Center, beef-pork). Indianapolis, IN 46285. NDA 017934.................. Similente Iletin Do. (insulin zinc suspension purified beef-pork). NDA 017939.................. Tagamet (cimetidine) GlaxoSmithKline. Injection, 150 mg/ mL. NDA 018084.................. Tolectin DS Ortho-McNeil (tolmetin sodium) Pharmaceutical, Capsules. Inc., c/o Johnson & Johnson Pharmaceutical Research & Development, LLC. NDA 018096.................. Dextrose and Sodium Hospira, Inc. Chloride Injection USP. NDA 018118.................. Lanoxicaps (digoxin) GlaxoSmithKline. Capsules. NDA 018201.................. Moduretic (amiloride Merck & Co., Inc. HCl/HCTZ) Tablets. NDA 018380.................. Sodium Chloride Do. Irrigation USP. NDA 018590.................. Aminocaproic Acid Baxter Healthcare Injection USP, 250 Corp. mg/mL. NDA 018776.................. Norcuron (vecuronium Organon USA Inc., c/ bromide) Injection. o Schering-Plough Corp. NDA 018869.................. Nimotop (nimodipine) Bayer Healthcare Capsules. Pharmaceuticals, Inc., P.O. Box 1000, Montville, NJ 07045. NDA 019008.................. Bretylium Tosylate Hospira, Inc., 275 in Dextrose North Field Dr., Injection USP. Bldg. H2, Lake Forest, IL 60045- 5046. NDA 019030.................. Bretylium Tosylate Hospira, Inc. Injection USP, 50 mg/mL. NDA 019058.................. Tenormin (atenolol) AstraZeneca Injection, 5 mg/10 Pharmaceuticals LP, mL. 1800 Concord Pike, P.O. Box 8355, Wilmington, DE 19803-89355. NDA 019091.................. Ismo (isosorbide Promius Pharma, LLC, mononitrate) 200 Somerset Tablets, 20 mg. Corporate Blvd., 7th Floor, Bridgewater, NJ 08807. NDA 019165.................. Protamine Zinc Eli Lilly and Co. (insulin zinc suspension beef). NDA 019168.................. Lente Insulin Do. (insulin zinc suspension beef). NDA 019204.................. Cartrol (carteolol Abbot Laboratories. HCl) Tablets. NDA 019377.................. Humulin L (insulin Do. zinc suspension recombinant human) Injection. NDA 019434.................. Tagamet (cimetidine GlaxoSmithKline. HCl) in Sodium Chloride Injection, Equivalent to (EQ) 6 mg Base/mL. NDA 019546.................. Dynacirc SmithKline Beecham (isradipine) Corp., d/b/a Capsules. GlaxoSmithKline, One Franklin Plaza, 200 North 16th St., Philadelphia, PA 19102. NDA 019561.................. Micro-K LS KV Pharmaceutical (potassium Co., One Corporate chloride). Woods Dr., Bridgeton, MO 63044. NDA 019571.................. Humulin U (insulin Eli Lilly and Co. zinc suspension extended recombinant human) Injection. NDA 019583.................. Relafen (nabumetone) SmithKline Beecham Tablets. Corp., c/o GlaxoSmithKline, 2301 Renaissance Blvd., RN210, P.O. Box 61540, King of Prussia, PA 19406. NDA 019591.................. Lariam (mefloquine Hoffmann-La Roche HCl) Tablets, 250 Inc. mg. NDA 019638.................. Arduan (pipecuronium Organon USA Inc., c/ bromide) Injection. o Schering-Plough Corp. NDA 019735.................. Floxin (ofloxacin) Ortho-McNeil-Janssen Tablets. Pharmaceuticals, Inc., c/o Johnson & Johnson Pharmaceutical Research & Development, LLC, P.O. Box 300, 920 Route 202 South, Raritan, NJ 08869- 0602. NDA 019979.................. Ticlid (ticlopidine Roche Palo Alto LLC, HCl) Tablets. c/o Hoffmann-La Roche Inc., 340 Kingsland St., Nutley, NJ 07110- 1199. NDA 020027.................. Cardizen (diltiazem Biovail Technologies HCl) Injection. Ltd., On Behalf of Biovail Laboratories International SRL, 700 Route 202/206 North, Bridgewater, NJ 08807. NDA 020100.................. Humulin 50/50 Eli Lilly and Co. (insulin recombinant human and insulin suspension isophane recombinant human). NDA 020269.................. Dobutamine HCl in 5% Hospira, Inc. Dextrose Injection. NDA 020507.................. Teczem (enalapril Biovail maleate/diltiazem Technologies, Ltd. maleate) Extended- Release Tablets. NDA 020548.................. Flovent (fluticasone GlaxoSmithKline. propionate) Inhalation Aerosol \1\. NDA 020549.................. Flovent (fluticasone Do. propionate) Inhalation Powder. NDA 020668.................. Lexxel (enalapril AstraZeneca maleate and Pharmaceuticals LP. felodipine) Extended-Release Tablets. NDA 020792.................. Cardizem (diltiazem Biovail HCl) Injection. Technologies, Ltd. NDA 020906.................. Etopophos Bristol-Myers Squibb (estoposide Co. phosphate) Injection. NDA 020939.................. Diltiazem HCl Biovail Extended-Release Technologies, Ltd. Capsules, 120 mg, 180 mg, 240 mg, 300 mg, 360 mg, and 420 mg. [[Page 33312]] NDA 020961.................. Vitravene Novartis (fomivirsen sodium) Pharmaceuticals Injection. Corp., One Health Plaza, East Hanover, NJ 07936- 1080. NDA 020966.................. Sporanox Ortho-McNeil-Janssen (itraconazole) Pharmaceuticals, Injection. Inc., c/o Johnson & Johnson Pharmaceutical Research & Development, LLC. NDA 021084.................. Skin Exposure U.S. Army Medical Reduction Paste Material Against Chemical Development Warfare Agent Activity, c/o (SERPACWA) Office of Surgeon (polyetrafluoroethy General, 1430 lene and Veterans Dr., Fort perfluoropolymethyl Detrick,